Ashvarya Mangla, MD Interventional and Structural Cardiologist, OSF HealthCare Cardiovascular Institute
Heart valve disease affects an estimated 11 million Americans, with risk increasing significantly as we age.
Join us as we explore how OSF HealthCare Cardiovascular Institute is at the forefront of the latest advancements in heart valve procedures. We’ll highlight the growth of the structural heart program at OSF, including milestones in transcatheter aortic valve replacement (TAVR), the expansion of MitraClip procedures for mitral valve regurgitation and the recent introduction of TriClip for tricuspid valve repair — making OSF one of only two locations in Illinois offering this option.
Host Shelli Dankoff chats with OSF cardiologists Ashvarya Mangla, MD, and Sudhir Mungee, MD, about common types of heart valve disease and how minimally invasive procedures can offer effective treatment with shorter hospital stays and recovery times.
Ashvarya Mangla, MD Interventional and Structural Cardiologist, OSF HealthCare Cardiovascular Institute
Sudhir Mungee, MD Director, Structural Heart, OSF HealthCare Cardiovascular Institute